US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.45

+0.34251.22%

Volume:310

Turnover:8.82K

Market Cap:1.42M

PE:- -

High:28.45

Open:28.45

Low:28.45

Close:28.11

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:3.22

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS

AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says

MT Newswires Live

European Shares Gain as Genmab Jumps, Bond Yields Retreat

LIVE Markets-a Health Boost for the STOXX

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

Align Technology Inc. Stock Underperforms Monday When Compared to Competitors

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live

Align Technology Shares Fall After Evercore ISI Downgrade

MT Newswires Live

Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL

AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Moderately bullish activity in Hims and Hers Health with shares up 3.07%

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/GLAM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.45,"timestamp":1791571107234,"preClose":28.1075,"halted":0,"volume":310,"delay":0,"changeRate":0.012185359779418217,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Trading","change":0.3425,"latestTime":"10-09 14:49:52 EDT","open":28.45,"high":28.45,"low":28.4499,"amount":8818.467700000001,"amplitude":0.000004,"askPrice":28.57,"askSize":1400,"bidPrice":28.52,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":28.1075,"nav":28.05,"aum":1402500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.0701,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":-0.0374,"changeRate":-0.001331,"amplitude":0},"volumeRatio":3.223654,"impliedVol":0.0865,"impliedVolPercentile":0.1},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.223654,"shares":50000,"dividePrice":0,"high":28.45,"amplitude":0.000004,"preClose":28.1075,"low":28.4499,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.45,"eps":0,"divideRate":0,"volume":310,"delay":0,"ttmEps":0,"open":28.45,"prevYearClose":25.82,"prevWeekClose":27.6182,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":27.6182,"twentyDayClose":28.0254,"sixtyDayClose":27.8939},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673018199","title":"Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018199?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA8YWCC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGNG","LU0708994859.HKD","BK4550","LU0472753341.HKD","LU0456855351.SGD","PPH","LU1496350502.SGD","GLAM","LU1244550577.SGD","XLV","LU1244550221.USD","BK4581","LU1720051017.SGD","LU0234572021.USD","VHT","FTXH","TRUH","LU0912757837.SGD","LU1585245621.USD","IYH","LU0211327993.USD","LU0211328371.USD","LU1267930573.SGD","LU1718418525.SGD","MEDX","ABBV","LU1670627923.USD","LU2087621335.USD","IE00BLSP4239.USD","LU0417517546.SGD","SG9999015978.USD","FHLC","IXJ","IE00BDGV0183.EUR","LU1670628061.USD","PJP","LU0943347566.SGD","RXL","IE00B19Z3581.USD","JDOC","LU0949170772.SGD","LU0320765646.SGD","LU1037948541.HKD","LU1934455277.USD","LU0859254822.USD","LU1023059063.AUD","LU1236620750.USD","LU0170899867.USD","LU0029864427.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050342","title":"AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050342?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:41","pubTimestamp":1791304881,"startTime":"0","endTime":"0","summary":"AbbVie's  Epkinly could become a preferred frontline option in diffuse large B-cell lymphoma, as its phase 3 result looks favorable against other recently positive regimens on a cross-trial basis, UBS Securities said.The investment firm said in a Monday note that the data would support use of Epkinly with R-CHOP chemotherapy, potentially ahead of combinations such as Roche's Polivy and glofitimab.UBS sees a potential multi-billion-dollar opportunity, versus consensus peak sales of just $1 billion to $2 billion for AbbVie, which splits economics with Genmab.The brokerage also noted the study succeeded in a broader patient population than expected, and said it still needs to see full data and safety, which could come at ASH in December.UBS has a neutral rating on AbbVie, with a $260 price target.Price: 267.95, Change: +2.19, Percent Change: +0.83","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0726765562.USD","RXL","LU0069063385.USD","LU1267930573.SGD","TRUH","LU1061106388.HKD","SG9999011175.SGD","LU0310799852.SGD","LU1551013425.SGD","LU0689626769.HKD","GLAM","IE00BDGV0183.EUR","SG9999015978.USD","IE00B3PB1722.GBP","LU2237443382.USD","BK4581","LU0198837287.USD","LU0472753341.HKD","IXJ","LU0256863811.USD","AGNG","FTXH","LU1934455277.USD","LU1718418525.SGD","FHLC","LU2433249047.HKD","XLV","IE0002270589.USD","LU0234572021.USD","LU1923622614.USD","PJP","LU0203345920.USD","SG9999015945.SGD","IYH","JDOC","VHT","IE0002141913.USD","LU0211328371.USD","PPH","LU0029864427.USD","LU2237443895.HKD","LU1074936037.SGD","LU0114720955.EUR","ABBV","LU0289739699.SGD","LU2089984988.USD","MEDX","LU1496350171.SGD","LU0456855351.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300037","title":"European Shares Gain as Genmab Jumps, Bond Yields Retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673300037?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:51","pubTimestamp":1791276686,"startTime":"0","endTime":"0","summary":"European shares gain as Genmab jumps, bond yields retreatOct 6 (Reuters)-European shares rose towards one-week highs on Tuesday, buoyed by gains in healthcare stocks after Genmab's upbeat drug-trial r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL4N45S0H3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","FTXH","LU0661504455.SGD","LU0198837287.USD","XLV","LU2129689431.USD","IE00BGHQF631.EUR","LU1585245621.USD","LU2237443895.HKD","LU0203345920.USD","LU0472753341.HKD","LU1929549753.HKD","GLAM","LU0114720955.EUR","SG9999015945.SGD","LU1162221912.USD","FHLC","IE0002141913.USD","IE00B2B36J28.USD","LU0861579265.USD","LU1989771016.USD","IXJ","PJP","MEDX","IE00B3PB1722.GBP","VHT","PPH","BK4559","TRUH","LU1551013342.USD","LU0738911758.USD","LU1057294990.SGD","LU1061106388.HKD","LU2089984988.USD","LU1236620750.USD","LU1718418525.SGD","LU0234570918.USD","LU1496350171.SGD","LU2133065610.SGD","JDOC","RXL","SG9999001440.SGD","AGNG","LU1670627923.USD","LU2237443382.USD","LU0203347892.USD","BK4534","LU0965508806.USD","LU1732799900.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079034","title":"LIVE Markets-a Health Boost for the STOXX","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079034","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079034?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:54","pubTimestamp":1791273288,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-A health boost for the STOXXAdds blog postSTOXX 600 up 0.8%Healthcare stocks lead gains, boosted by 8% jump in Genmab sharesWall St futures steadyWelcome to the home for real-time coverag","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL6N45S0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000WAW04H5.SGD","LU1162221912.USD","LU1551013425.SGD","LU0949170772.SGD","LU0395794307.EUR","SG9999015952.SGD","LU1093756325.SGD","LU0661504455.SGD","ABBV","LU0256863811.USD","PPH","RXL","SG9999001440.SGD","BK4139","LU0211327993.USD","LU0128525929.USD","LU2129689514.USD","LU2468319806.SGD","BK4533","JDOC","LU1236620750.USD","LU2089984988.USD","IE00BVYPNV92.GBP","BK4550","LU2433249047.HKD","LU0122379950.USD","LU0203345920.USD","XLV","FTXH","LU0320765646.SGD","BK4534","LU0289739699.SGD","IE0009355771.USD","PJP","LU0726765562.USD","GLAM","LU0310799852.SGD","IE00B3PB1722.GBP","VHT","LU1720051017.SGD","AGNG","TRUH","IYH","LU1839511570.USD","LU2357627491.SGD","MEDX","FHLC","LU0029864427.USD","IXJ","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673103450","title":"Genmab at 3-Year High After Blood Cancer Drug Combination Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673103450","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673103450?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:18","pubTimestamp":1791271123,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab at 3-year high after blood cancer drug combination study results** Shares in GenmabGMAB.COrise around 8%to their highest in three years, hitting top of STOXX 600.STOXXindex** Genmab and Ab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL8N45S0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","MEDX","LU2357305700.SGD","LU1934455863.HKD","LU1244550494.USD","FHLC","FTXH","IE00B19Z3581.USD","LU1929549753.HKD","LU1732800096.USD","IXJ","XLV","IE00B42XCP33.USD","LU0456855351.SGD","LU0795875086.SGD","LU1732799900.SGD","IYH","LU1003077747.HKD","LU0708994859.HKD","LU0912757837.SGD","RXL","VHT","LU0942090050.USD","LU0203345920.USD","GLAM","IE0000B7K699.USD","LU0417517546.SGD","LU1037948541.HKD","LU2237443622.USD","IE000MB6IJN5.SGD","SG9999003800.SGD","IE00BDGV0183.EUR","LU0868494617.USD","PJP","ABBV","LU2129689514.USD","IE00BSNM7G36.USD","AGNG","LU0472753341.HKD","SG9999001440.SGD","BK4139","LU0859254822.USD","BK4550","LU1989772923.USD","JDOC","LU0211328371.USD","TRUH","LU0882574055.USD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673082351","title":"Align Technology Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673082351","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673082351?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:17","pubTimestamp":1791235020,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  shed 2.15% to $140.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's third consecutive day of losses.Align Technology Inc. closed 29.83% below its 52-week high of $200.44, which the company achieved on April 21st.The stock underperformed when compared to some of its competitors Monday, as Zimmer Biomet Holdings Inc.  rose 3.72% to $91.57 and Dentsply Sirona Inc.  fell 1.27% to $8.56.Trading volume  eclipsed its 50-day average volume of 909,671.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU0130517989.USD","LU2023250504.SGD","LU0128525929.USD","GLAM","LU0477156953.USD","LU2023250843.SGD","LU1267930490.SGD","LU0130102774.USD","LU1917777945.USD","XRAY","ZBH","LU1267930573.SGD","BK4534","LU1974910355.USD","BK4588","ALGN","LU0889566641.SGD","BK4504","LU0648001328.SGD","IE00B19Z3B42.SGD","LU1201861249.SGD","LU0310800379.SGD","LU0980610538.SGD","BK4198","BK4566","BK4082","IE0002270589.USD","LU0310799852.SGD","LU0211328371.USD","LU0708994859.HKD","LU0211327993.USD","LU0792757196.USD","LU2106854487.HKD","LU0006061336.USD","IE00B19Z3581.USD","BK4585","IE00B7SZLL34.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","VHT","LU0114720955.EUR","LU0124676726.USD","LU1934455194.USD","IE0000B7K699.USD","SG9999001440.SGD","LU0726765562.USD","LU1093756168.USD","LU0289739343.SGD","XLV","LU0211328371.USD","LU1496350171.SGD","LU2347655073.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","RXL","IE00BN8TJ469.HKD","LU0058720904.USD","LU2237443622.USD","LU0170899867.USD","LU1061106388.HKD","LU1732799900.SGD","LU1244550494.USD","LU1732800096.USD","LU1551013342.USD","IE00BVYPNV92.GBP","LU2237443465.HKD","LU2433249047.HKD","LU1162221912.USD","LU1934455277.USD","IE00BSNM7G36.USD","IYH","LU0553294199.USD","BK4588","LU1929549753.HKD","LU0289739699.SGD","LU2357627491.SGD","LU2125909247.SGD","LU2347655156.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","SG9999015978.USD","LU0256863902.USD","IE0004445239.USD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU0203347892.USD","LU2089283258.USD","LU0432979614.USD","FHLC","LU0943347566.SGD","LU0859254822.USD","LU1074936037.SGD","LU0912757837.SGD","IE000F7OJYX1.SGD","LU1670628061.USD","LU1236620834.HKD","LU0057025933.USD","LU2089284900.SGD","LU0795875169.SGD","IE00BJJMRZ35.SGD","LU0029864427.USD","LU0882574055.USD","LU0234570918.USD","LU0310800379.SGD","LU1037948541.HKD","LU1057294990.SGD","LU1551013425.SGD","IE000WAW04H5.SGD","LU0456855351.SGD","LU1989772840.SGD","LU2089984988.USD","SG9999015986.USD","LU0069063385.USD","LU1934455863.HKD","LU0985320562.USD","SG9999011175.SGD","LU0310799852.SGD","TRUH","LU1670627923.USD","BK4585","LU0868494617.USD","LU1430594728.SGD","LU2087621335.USD","LU1585245621.USD","LU1923622614.USD","LU1003077747.HKD","LU0289961442.SGD","LU1023059063.AUD","LU0965509101.SGD","LU0203345920.USD","SG9999015945.SGD","BK4550","IE00B42XCP33.USD","AGNG","ABBV","GLAM","LU0417517546.SGD","LU1989772923.USD","BK4534","LU1236620750.USD","LU0965509283.SGD","LU0708994859.HKD","LU0965508806.USD","LU2125909593.SGD","IE000BZT7R73.USD","LU0098860793.USD","LU0158827948.USD","LU1291159041.SGD","IE0009355771.USD","LU2023251221.USD","LU1244550577.SGD","LU0795875086.SGD","LU0395794307.EUR","LU1983299246.USD","LU2129689514.USD","MEDX","LU2357305700.SGD","PJP","LU0689626769.HKD","IE00B3PB1722.GBP","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU0823416689.USD","LU0198837287.USD","LU1989771016.USD","LU0472753341.HKD","IE000SO60NU8.SGD","IE00BGHQF631.EUR","LU0128525929.USD","LU0942090050.USD","LU0868494708.USD","LU2468319806.SGD","LU0320765646.SGD","LU1496350502.SGD","LU1718418525.SGD","LU2112291526.USD","LU2129689605.HKD","LU0256863811.USD","LU2237443895.HKD","BK4566","BK4139","LU0949170772.SGD","LU2129689431.USD","LU0820561818.USD","BK4581","LU0861579265.USD","LU1548497426.USD","LU1267930573.SGD","IE00B2B36J28.USD","LU0211327993.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU1244550221.USD","LU2237443978.SGD","IE00BDGV0183.EUR","IE0002141913.USD","LU0122379950.USD","LU2133065610.SGD","BK4533","LU1839511570.USD","LU0661504455.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0511384066.AUD","LU1267930490.SGD","LU0234572021.USD","LU1720051017.SGD","SG9999015952.SGD","BK4559","IE00BFTCPJ56.SGD","JDOC","LU0545039389.USD","LU0820561909.HKD","PPH","FTXH","LU1093756325.SGD","LU1037948897.HKD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","SG9999015978.USD","BK4550","GLAM","IE000SO60NU8.SGD","LU1236620750.USD","FHLC","IYH","LU0122379950.USD","LU0943347566.SGD","LU0553294199.USD","LU1934455863.HKD","LU0320765646.SGD","BK4588","FTXH","LU0170899867.USD","BK4534","LU1732799900.SGD","LU2023251221.USD","IE00B3PB1722.GBP","LU1037948541.HKD","MEDX","LU1720051108.HKD","LU1585245621.USD","LU0158827948.USD","LU1430594728.SGD","LU1023059063.AUD","XLV","ABBV","LU1162221912.USD","LU0661504455.SGD","LU1236620834.HKD","LU1267930573.SGD","IE0002141913.USD","IE0004445239.USD","JDOC","IXJ","TRUH","IE000BZT7R73.USD","LU0203345920.USD","PPH","RXL","IE00BGHQF631.EUR","PJP","VHT","LU2237443978.SGD","AGNG","IE00BDGV0183.EUR","LU0234570918.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673812780","title":"Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673812780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673812780?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023251221.USD","BK4534","LU1585245621.USD","LU0122379950.USD","BK4550","LU1267930573.SGD","JDOC","SG9999015978.USD","IXJ","MEDX","LU1934455863.HKD","RXL","ABBV","IE00B3PB1722.GBP","IE00BDGV0183.EUR","BK4566","LU0170899867.USD","LU1162221912.USD","LU1732799900.SGD","LU2237443978.SGD","TRUH","IYH","IE000BZT7R73.USD","AGNG","LU0128525929.USD","BK4588","XLV","LU1037948541.HKD","IE0004445239.USD","PPH","PJP","LU0661504455.SGD","IE0002141913.USD","IE00BGHQF631.EUR","FTXH","LU1720051108.HKD","LU0158827948.USD","FHLC","LU0320765646.SGD","LU1023059063.AUD","LU0553294199.USD","VHT","LU1236620750.USD","LU0943347566.SGD","LU0234570918.USD","LU1236620834.HKD","LU0203345920.USD","LU1430594728.SGD","IE000SO60NU8.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220081","title":"Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673220081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0211327993.USD","LU0738911758.USD","LU1585245621.USD","BK4139","JDOC","LU1720051017.SGD","PPH","IXJ","LU0708994859.HKD","LU1551013425.SGD","LU0689626769.HKD","IE00BGHQF631.EUR","LU2087621335.USD","AGNG","XLV","MEDX","LU1267930573.SGD","LU0114720955.EUR","PJP","GLAM","LU0795875169.SGD","LU0912757837.SGD","LU1496350502.SGD","IYH","TRUH","LU2237443978.SGD","LU0823416689.USD","FHLC","LU2129689431.USD","LU0795875086.SGD","LU0124676726.USD","LU0417517546.SGD","LU2237443895.HKD","BK4581","LU0058720904.USD","IE00BSNM7G36.USD","FTXH","LU0158827948.USD","LU2357305700.SGD","LU0545039389.USD","LU0553294199.USD","LU1061106388.HKD","BK4534","LU0661504455.SGD","LU1003077747.HKD","LU1244550577.SGD","RXL","VHT","LU0203347892.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081273","title":"Abbvie Inc. Fy2026 Shr View $14.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081273?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTXH","MEDX","LU1003077747.HKD","LU0943347566.SGD","FHLC","PJP","ABBV","LU0122379950.USD","LU1983299246.USD","LU1732799900.SGD","IE00BJT1NW94.SGD","LU1720051108.HKD","LU0965509010.AUD","IE00B3PB1722.GBP","AGNG","GLAM","LU1061106388.HKD","LU0738911758.USD","LU1923622614.USD","BK4581","JDOC","LU2125909593.SGD","LU0417517546.SGD","LU1989772923.USD","LU2237443465.HKD","LU1057294990.SGD","SG9999003800.SGD","LU0098860793.USD","LU2125909247.SGD","LU2237443549.SGD","RXL","IXJ","LU1718418525.SGD","SG9999015952.SGD","LU0203345920.USD","TRUH","LU0058720904.USD","VHT","IYH","LU0256863902.USD","LU1267930573.SGD","LU2237443622.USD","LU1093756168.USD","PPH","XLV","LU2347655073.USD","LU0859254822.USD","LU0057025933.USD","SG9999015978.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081227","title":"Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081227?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2347655073.USD","IE00BN8TJ469.HKD","JDOC","LU1839511570.USD","PPH","LU2112291526.USD","IXJ","LU1934455194.USD","LU1023059063.AUD","LU1718418525.SGD","LU0949170772.SGD","AGNG","XLV","IE00B3PB1722.GBP","MEDX","PJP","GLAM","LU0256863811.USD","LU1244550221.USD","LU1496350502.SGD","IYH","LU2125909593.SGD","TRUH","FHLC","LU0395794307.EUR","LU0170899867.USD","LU2237443465.HKD","IE00BLSP4452.SGD","LU2237443622.USD","BK4581","LU0058720904.USD","FTXH","LU0511384066.AUD","LU0472753341.HKD","LU2237443382.USD","LU1236620750.USD","LU0289961442.SGD","SG9999001440.SGD","BK4534","LU0861579265.USD","LU2089283258.USD","LU1929549753.HKD","RXL","SG9999015945.SGD","VHT","LU1037948897.HKD","IE00B19Z3B42.SGD","ABBV","LU0689472784.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673819760","title":"Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673819760","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673819760?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:50","pubTimestamp":1791229824,"startTime":"0","endTime":"0","summary":"Genmab  and AbbVie  said that adding their drug epcoritamab to a standard chemotherapy mix helped people with an aggressive form of blood cancer stay cancer-free longer than chemotherapy alone.The combination cut the risk of the cancer getting worse or the patient dying by 51% compared with standard treatment alone, the companies said Monday in a statement. Results were from a large study in newly diagnosed patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma.The treatment paired epcoritamab with R-CHOP, a long-used chemotherapy regimen. The companies said the safety of the combination looked generally similar to what doctors already expect from each drug on its own.Because the treatment is still experimental, Genmab and AbbVie plan to meet with regulators around the world to discuss next steps.Genmab shares rose 11% in Monday trading, and AbbVie gained 1.3%.Price: 38.72, Change: +3.97, Percent Change: +11.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525929.USD","LU0942090050.USD","LU0965509101.SGD","LU1244550221.USD","LU1839511570.USD","IE00BLSP4239.USD","IYH","LU1989772840.SGD","LU2347655156.SGD","LU0689626769.HKD","LU2125909593.SGD","GMAB","JDOC","FHLC","ABBV","RXL","IE00BSNM7G36.USD","LU2129689605.HKD","PPH","TRUH","IE000MB6IJN5.SGD","XLV","LU0158827948.USD","LU1162221912.USD","BK4581","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","SG9999003800.SGD","LU2237443549.SGD","GLAM","MEDX","IXJ","LU0795875169.SGD","LU2089284900.SGD","LU0256863811.USD","PJP","LU1983299246.USD","LU0395794307.EUR","IE00B4R5TH58.HKD","LU2089283258.USD","LU1057294990.SGD","LU2237443382.USD","LU2347655073.USD","VHT","LU1923622614.USD","LU2237443465.HKD","LU0859254822.USD","FTXH","SG9999015945.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673815430","title":"Align Technology Shares Fall After Evercore ISI Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2673815430","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673815430?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:49","pubTimestamp":1791229798,"startTime":"0","endTime":"0","summary":"Align Technology  shares were down about 1.9% in Monday trading after Evercore ISI downgraded the stock to in-line from outperform and cut its price target to $155 from $220.Intraday trading volume was more than 1.2 million shares, compared with a daily average of about 891,000.Price: 141.06, Change: -2.68, Percent Change: -1.86","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALGN","LU1974910355.USD","BK4534","BK4585","LU2106854487.HKD","LU2023250504.SGD","BK4198","BK4504","BK4588","GLAM","LU1917777945.USD","LU2023250843.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673811030","title":"Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673811030","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673811030?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:47","pubTimestamp":1791229638,"startTime":"0","endTime":"0","summary":"An announcement from Genmab ( ($GMAB) ) is now available. Genmab and AbbVie reported on October 5, 2026, that their Phase 3 EPCORE DLBCL-2 trial sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","PJP","RXL","TRUH","LU2468319806.SGD","IXJ","LU1037948897.HKD","LU1718418525.SGD","XLV","LU0823416689.USD","PPH","BK4581","BK4559","LU1236620750.USD","AGNG","LU0689626769.HKD","IE000SO60NU8.SGD","LU1929549753.HKD","LU2089284900.SGD","LU0158827948.USD","LU2237443978.SGD","BK4588","LU2237443382.USD","GLAM","FTXH","BK4585","LU1496350502.SGD","LU1551013342.USD","ABBV","FHLC","LU2237443465.HKD","LU2357305700.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU0122379950.USD","LU1670628061.USD","IE00B3PB1722.GBP","IE00BDGV0183.EUR","IE000F7OJYX1.SGD","LU0965509101.SGD","VHT","LU0289739699.SGD","BK4550","LU0965509283.SGD","IYH","JDOC","LU1244550221.USD","LU1074936037.SGD","LU1720051017.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673363081","title":"AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673363081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673363081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:36","pubTimestamp":1791228977,"startTime":"0","endTime":"0","summary":"AbbVie blood cancer drug combo cuts risk of progression or death in late-stage studyOct 5 (Reuters)-Danish biotech firm GenmabGMAB.COand US drugmaker AbbVieABBV.Nsaid on Monday their combination treat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU1244550221.USD","LU0395794307.EUR","ABBV","GLAM","LU0158827948.USD","IE00BSNM7G36.USD","IXJ","LU1989772840.SGD","LU2237443382.USD","LU2347655156.SGD","TRUH","SG9999003800.SGD","LU1162221912.USD","LU0942090050.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0859254822.USD","VHT","LU1983299246.USD","XLV","LU2129689605.HKD","MEDX","RXL","BK4581","FHLC","IE00B4R5TH58.HKD","IE00BLSP4239.USD","LU1923622614.USD","LU2125909593.SGD","LU0689626769.HKD","IYH","LU2237443549.SGD","LU2089284900.SGD","LU1057294990.SGD","PJP","FTXH","LU0795875169.SGD","IE00BN8TJ469.HKD","IE00BVYPNW00.USD","AGNG","LU1839511570.USD","IE000MB6IJN5.SGD","LU0256863811.USD","LU2237443465.HKD","LU0965509101.SGD","LU0128525929.USD","LU2347655073.USD","PPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311081","title":"Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311081","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:55","pubTimestamp":1791226515,"startTime":"0","endTime":"0","summary":"Genmab A/S (GMAB) and AbbVie (ABBV) announced “positive” topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU1551013342.USD","LU2433249047.HKD","LU0456855351.SGD","TRUH","LU2089284900.SGD","LU1934455194.USD","GMAB","AGNG","LU1074936037.SGD","RXL","LU1267930490.SGD","LU0511384066.AUD","VHT","SG9999001440.SGD","FTXH","LU0395794307.EUR","LU0726765562.USD","IYH","LU0289739699.SGD","LU0211328371.USD","IXJ","LU0868494617.USD","LU1585245621.USD","LU2087621335.USD","LU0203345920.USD","LU0256863902.USD","MEDX","LU0058720904.USD","LU1720051108.HKD","LU2023251221.USD","PJP","SG9999015986.USD","LU2357627491.SGD","IE00BJT1NW94.SGD","PPH","IE000MB6IJN5.SGD","LU1496350171.SGD","LU0069063385.USD","LU0057025933.USD","LU2125909593.SGD","FHLC","GLAM","LU0417517546.SGD","LU1023059063.AUD","LU1934455277.USD","LVIG","XLV","JDOC","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089429","title":"Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089429?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226259,"startTime":"0","endTime":"0","summary":"Genmab says Phase 3 EPCORE DLBCL-2 trial shows epcoritamab plus R-CHOP cuts progression or death risk 51% in newly diagnosed DLBCLGenmab, AbbVie reported positive topline Phase 3 results for epcoritam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLWBPbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","IE00BKPKM429.USD","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","FTXH","XLV","LU2095319765.USD","LU0234570918.USD","TRUH","BCDF","LU0158827948.USD","ABBV","BK4581","IE00BN0W2V16.EUR","LU0289961442.SGD","LU0912757837.SGD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","IXJ","IE00BQXX3F31.USD","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","IE00BGHQF748.EUR","LU1923622614.USD","LU0882574055.USD","BK4588","LU1989771016.USD","NDAQ","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081372","title":"Moderately bullish activity in Hims and Hers Health with shares up 3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081372?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226213,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up 89c, or 3.07%, near $29.89. Options volume roughly in line with average ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-3-07-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-3-07-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","HMYY","HIMY","HIMZ","BK4196","HIMS","HEAL","HIYY","HIMC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894940","title":"Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","LU1551013425.SGD","FTXH","XLV","LU0234570918.USD","TRUH","LU0158827948.USD","ABBV","BK4581","LU0289961442.SGD","LU0912757837.SGD","IE0000B7K699.USD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00BBT3K403.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","LU0965509010.AUD","IXJ","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","LU1923622614.USD","LU0882574055.USD","BK4588","LU1267930573.SGD","LU0553294199.USD","LU1989771016.USD","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}